Helsinn Therapeutics

AKYNZEO

  1. Home
  2.  / 
  3. J Code
  4.  / AKYNZEO – J8655

Manufacturer:

Helsinn Therapeutics

Name:

AKYNZEO

HCPCS Code Descriptor:

Netupitant 300 mg and palonosetron 0.5 mg, oral

Category:

J Code

HCPCS:

J8655

NDC(s):

69639-0101-01

Primary Type:

Oncology-Anti-Emetic

Generic Status:

Single-Source

Route of Administration:

Oral

About:

AKYNZEO is an Oncology-Anti-Emetic drug manufactured by Helsinn Therapeutics and administered via the Oral route of administration. The J Code: J8655 is aligned to the drug AKYNZEO.

Access Pricing and More By Registering

HCPCS Added Date:

1/1/16

HCPCS Effective Date:

1/1/19

HCPCS Short Description:

Oral netupitant, palonosetro

Billing and Coding Guide:

https://helsinnreimbursement.com/pdfs/V-AKYN-US-0544-AKYNZEO-Capsules-Billing-Coding-Guide.pdf

Patient Assistance:

https://helsinnreimbursement.com/

https://helsinnreimbursement.com/